News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
365,237 Results
Type
Article (22545)
Company Profile (152)
Press Release (342539)
Multimedia
Podcasts (85)
Webinars (14)
Section
Business (111487)
Career Advice (933)
Deals (19813)
Drug Delivery (99)
Drug Development (52824)
Employer Resources (87)
FDA (8207)
Job Trends (8171)
News (195998)
Policy (18196)
Tag
Academia (848)
Accelerated approval (7)
Adcomms (20)
Allergies (51)
Alliances (29216)
ALS (64)
Alzheimer's disease (756)
Antibody-drug conjugate (ADC) (119)
Approvals (8231)
Artificial intelligence (207)
Autoimmune disease (24)
Automation (10)
Bankruptcy (189)
Best Places to Work (5775)
BIOSECURE Act (14)
Biosimilars (113)
Biotechnology (76)
Bladder cancer (56)
Brain cancer (23)
Breast cancer (164)
Cancer (1534)
Cardiovascular disease (145)
Career advice (760)
Career pathing (21)
CAR-T (73)
CDC (10)
Cell therapy (192)
Cervical cancer (7)
Clinical research (44730)
Collaboration (635)
Compensation (267)
Complete response letters (26)
COVID-19 (1182)
CRISPR (36)
C-suite (236)
Cystic fibrosis (78)
Data (1750)
Decentralized trials (2)
Denatured (21)
Depression (39)
Diabetes (184)
Diagnostics (2056)
Digital health (9)
Diversity (7)
Diversity, equity & inclusion (24)
Drug discovery (100)
Drug pricing (135)
Drug shortages (33)
Duchenne muscular dystrophy (84)
Earnings (41173)
Editorial (34)
Employer branding (12)
Employer resources (82)
Events (57351)
Executive appointments (595)
FDA (9097)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (477)
Gene editing (72)
Generative AI (19)
Gene therapy (185)
GLP-1 (677)
Government (1979)
Grass and pollen (3)
Guidances (101)
Healthcare (6906)
HIV (19)
Huntington's disease (17)
IgA nephropathy (31)
Immunology and inflammation (114)
Immuno-oncology (10)
Indications (25)
Infectious disease (1276)
Inflammatory bowel disease (98)
Inflation Reduction Act (10)
Influenza (27)
Intellectual property (79)
Interviews (126)
IPO (8163)
IRA (48)
Job creations (2631)
Job search strategy (685)
Kidney cancer (8)
Labor market (37)
Layoffs (321)
Leadership (17)
Legal (4469)
Liver cancer (34)
Longevity (6)
Lung cancer (226)
Lymphoma (127)
Machine learning (7)
Management (33)
Manufacturing (292)
MASH (62)
Medical device (2697)
Medtech (2700)
Mergers & acquisitions (12036)
Metabolic disorders (619)
Multiple sclerosis (63)
NASH (20)
Neurodegenerative disease (68)
Neuropsychiatric disorders (27)
Neuroscience (1179)
NextGen: Class of 2025 (2637)
Non-profit (1174)
Now hiring (33)
Obesity (376)
Opinion (205)
Ovarian cancer (46)
Pain (88)
Pancreatic cancer (61)
Parkinson's disease (111)
Partnered (11)
Patents (189)
Patient recruitment (86)
Peanut (19)
People (36343)
Pharmaceutical (76)
Pharmacy benefit managers (25)
Phase I (14048)
Phase II (19009)
Phase III (15068)
Pipeline (1070)
Policy (173)
Postmarket research (1701)
Preclinical (5111)
Press Release (29)
Prostate cancer (89)
Psychedelics (19)
Radiopharmaceuticals (183)
Rare diseases (316)
Real estate (3513)
Recruiting (34)
Regulatory (13228)
Reports (25)
Research institute (924)
Resumes & cover letters (145)
Rett syndrome (3)
RNA editing (7)
RSV (28)
Schizophrenia (74)
Series A (88)
Series B (55)
Service/supplier (7)
Sickle cell disease (42)
Special edition (17)
Spinal muscular atrophy (115)
Sponsored (15)
Startups (2246)
State (2)
Stomach cancer (10)
Supply chain (60)
Tariffs (61)
The Weekly (62)
Vaccines (339)
Venture capital (40)
Weight loss (263)
Women's health (19)
Worklife (8)
Date
Today (47)
Last 7 days (190)
Last 30 days (1016)
Last 365 days (17461)
2025 (9531)
2024 (19291)
2023 (21519)
2022 (28153)
2021 (28717)
2020 (26695)
2019 (22092)
2018 (17048)
2017 (18389)
2016 (17514)
2015 (20309)
2014 (16014)
2013 (13593)
2012 (14609)
2011 (14878)
2010 (13688)
Location
Africa (428)
Alabama (35)
Alaska (1)
Arizona (76)
Arkansas (8)
Asia (25970)
Australia (3468)
California (3480)
Canada (1405)
China (466)
Colorado (134)
Connecticut (134)
Delaware (106)
Europe (54693)
Florida (590)
Georgia (79)
Hawaii (1)
Idaho (17)
Illinois (330)
India (22)
Indiana (218)
Iowa (5)
Japan (180)
Kansas (68)
Kentucky (23)
Louisiana (4)
Maine (8)
Maryland (455)
Massachusetts (3846)
Michigan (59)
Minnesota (176)
Mississippi (2)
Missouri (32)
Montana (13)
Nebraska (11)
Nevada (26)
New Hampshire (14)
New Jersey (1328)
New Mexico (22)
New York (1011)
North Carolina (605)
North Dakota (3)
Northern California (1483)
Ohio (100)
Oklahoma (7)
Oregon (21)
Pennsylvania (786)
Puerto Rico (15)
Rhode Island (18)
South America (643)
South Carolina (8)
Southern California (1421)
Tennessee (49)
Texas (461)
United States (14373)
Utah (76)
Virginia (119)
Washington D.C. (54)
Washington State (273)
West Virginia (1)
Wisconsin (32)
365,237 Results for "boston pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NS Pharma Announces Strategic Alliance with Boston Children’s Hospital to Develop New Therapies for Rare Diseases
July 2, 2025
·
1 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Deals
Revolution Establishes Endless Cash Runway With $2B Royalty Pharma Deal
In May, Revolution Medicines projected its cash and equivalents of $2.1 billion would last into the second half of 2027. With new funding from Royalty Pharma, the biotech has withdrawn that runway end date.
June 24, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program
May 28, 2025
·
3 min read
Press Releases
Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform
June 2, 2025
·
5 min read
Clinical research
Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond
R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.
May 28, 2025
·
12 min read
·
Tristan Manalac
MASH
GSK Buys Phase III–Ready Liver Drug in Potential $2B Deal To Play in MASH Arena
GSK secures rights to Boston Pharmaceuticals’ efimosfermin alfa, which the pharma plans to develop for fatty liver diseases such as metabolic dysfunction-associated steatohepatitis and alcohol-related liver disease.
May 14, 2025
·
2 min read
·
Tristan Manalac
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Boston Institute of Biotechnology, LLC with BiBo Pharma Announce Groundbreaking Expansion to Revolutionize Global Biologics Production Capacity
December 20, 2024
·
3 min read
Press Releases
Defence Therapeutics to Attend Bio International Convention in Boston, June 2025
May 28, 2025
·
3 min read
1 of 36,524
Next
